[Tumor scintigraphy with cobalt bleomycin in ORL tumors].
Our experiences with cobalt bleomycin scintigraphy in the treatment planning of ORL tumors are described. 142 scintigrams taken from 127 patients have been examined. As is shown by our investigation, cobalt bleomycin scintigraphy is a good examination method, however, too much expenditure is needed to have the necessary data for therapy planning. To our opinion, the information obtained in oto-rhino-laryngology by an exact clinical examination is as good as that of cobalt bleomycin scintigraphy. Our treatment schemes had only to be revised in some exceptional cases.
D001761:Bleomycin / Q000031:analogs & derivatives; D003035:Cobalt; D003037:Cobalt Radioisotopes; D003131:Combined Modality Therapy; D006801:Humans; D008207:Lymphatic Metastasis; D010039:Otorhinolaryngologic Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy; D010347:Patient Care Planning; D011877:Radionuclide Imaging; D012588:Scintillation Counting / Q000295:instrumentation
D003037:Cobalt Radioisotopes; C030187:cobalt bleomycin; D001761:Bleomycin; D003035:Cobalt; C018021:cobaltous chloride
Tumorszintigraphie mit Kobaltbleomycin bei den ORL-Tumoren.